OverviewChartNewsTraderScreen

JP Morgan Put 155 ABBV 19.07.2024/  DE000JK8RAX5  /

EUWAX
14/06/2024  12:50:28 Chg.+0.001 Bid15:24:29 Ask15:24:29 Underlying Strike price Expiration date Option type
0.095EUR +1.06% 0.093
Bid Size: 10,000		 0.100
Ask Size: 10,000		 AbbVie Inc 155.00 USD 19/07/2024 Put
Newsfile Corp 13/06 BioMed X Launches New US Institute in New Haven, CT
GlobeNewswire 13/06 Anima Biotech to Present at the Society for Medicines Research’s Modulating RNA with Oligonucleotide...
GlobeNewswire 13/06 LifeSci Advisors Announces Appointment of Chris Howerton Ph.D.
GlobeNewswire 13/06 CEREVEL SHAREHOLDER REMINDER: Is $45 Per Share Enough for Cerevel (Nasdaq: CERE)? BFA Law is Investi...
GlobeNewswire 13/06 What Employees at the Fortune Best Workplaces in New York, Chicago, Texas, and the Bay Area Value Mo...
GlobeNewswire 12/06 US Gastroenterologists Express Anticipation for Approval of AbbVie’s Skyrizi in Ulcerative Colitis, ...
GlobeNewswire 12/06 OSE Immunotherapeutics KOL Investor Webinar on the Therapeutic Landscape and Unmet Medical Needs in ...
GlobeNewswire 11/06 CEREVEL ALERT: Is $45 Per Share Too Low for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and Urg...
GlobeNewswire 08/06 CEREVEL NEWS NOTIFICATION: BFA Law Alerts Cerevel (Nasdaq: CERE) Shareholders of Investigation into ...
GlobeNewswire 05/06 CEREVEL INVESTIGATION ALERT: Cerevel (Nasdaq: CERE) Investors are Encouraged to Contact BFA Law abou...
GlobeNewswire 05/06 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 05/06 OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR...
GlobeNewswire 04/06 Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire 04/06 BioVie Announces Formation of Advisory Board for Bezisterim in Long COVID
GlobeNewswire 03/06 Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes
GlobeNewswire 03/06 ACQUISITION NEWS: Cerevel’s (Nasdaq: CERE) $45 Merger Offer is Being Investigated for Being Too Low,...
GlobeNewswire 01/06 CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation ...
GlobeNewswire 30/05 OSE Immunotherapeutics Provides Business and Corporate Update
GlobeNewswire 29/05 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
GlobeNewswire 28/05 Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Imp...
GlobeNewswire 28/05 CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: C...
GlobeNewswire 28/05 Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
GlobeNewswire 25/05 CERE (NASDAQ) ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation; Contact BFA Law ...
GlobeNewswire 24/05 Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7...
GlobeNewswire 23/05 Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...